Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
34.47B | 32.87B | 30.73B | 28.55B | 25.45B | 24.61B | Gross Profit |
10.58B | 9.93B | 8.82B | 7.87B | 6.68B | 6.88B | EBIT |
3.27B | 2.89B | 2.40B | 1.82B | 1.06B | 1.17B | EBITDA |
4.59B | 4.19B | 3.61B | 3.09B | 2.02B | 2.29B | Net Income Common Stockholders |
2.22B | 2.13B | 1.55B | 1.11B | 529.11M | 772.44M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.77B | 7.67B | 6.31B | 5.21B | 5.31B | 1.89B | Total Assets |
23.99B | 23.06B | 21.11B | 19.66B | 18.59B | 15.32B | Total Debt |
522.00M | 520.86M | 551.73M | 609.56M | 1.11B | 1.23B | Net Debt |
-6.22B | -7.15B | -5.75B | -4.60B | -4.20B | -665.19M | Total Liabilities |
10.08B | 8.79B | 8.58B | 8.23B | 7.58B | 7.08B | Stockholders Equity |
13.91B | 14.26B | 12.53B | 11.43B | 11.00B | 8.24B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.22B | 2.12B | 1.87B | 1.52B | 744.22M | Operating Cash Flow |
0.00 | 3.64B | 2.91B | 2.65B | 1.90B | 1.53B | Investing Cash Flow |
0.00 | -2.36B | -1.13B | -1.70B | -439.73M | -146.47M | Financing Cash Flow |
0.00 | -761.14M | -687.86M | -1.04B | 1.95B | -999.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $2.39T | 20.69 | 8.55% | 1.73% | 3.60% | 6.61% | |
72 Outperform | ¥14.28B | 5.77 | 1.33% | 17.70% | 68.00% | ||
66 Neutral | ¥17.96B | 18.45 | 3.49% | 9.70% | 45.81% | ||
64 Neutral | $8.88B | 14.67 | 4.78% | 173.89% | 3.39% | 2.18% | |
63 Neutral | ¥42.26B | 17.64 | 2.45% | 6.48% | 18.62% | ||
54 Neutral | ¥1.95B | 6.53 | 3.45% | 2.17% | ― |
Waseda Academy Co., Ltd. announced a change in its major shareholder as of March 31, 2025. The change involves Shinichi Kawabata, who maintains his position as the second-largest shareholder with a slight decrease in his voting rights ratio from 10.10% to 9.96%. This adjustment in shareholder structure is confirmed not to impact the company’s business performance.